178 related articles for article (PubMed ID: 38420199)
1. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells.
Wang X; Ding R; Fu Z; Yang M; Li D; Zhou Y; Qin C; Zhang W; Si L; Zhang J; Chai Y
Front Pharmacol; 2024; 15():1303732. PubMed ID: 38420199
[No Abstract] [Full Text] [Related]
2. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-455-3p inhibits osteosarcoma progression via HSF1 downregulation.
Wang C; Zhang D; Wang L; Wang W
J Orthop Sci; 2023 Sep; 28(5):1157-1164. PubMed ID: 35989156
[TBL] [Abstract][Full Text] [Related]
4. MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells.
Liu C; Han X; Li B; Huang S; Zhou Z; Wang Z; Wang W
Cancer Manag Res; 2021; 13():6879-6889. PubMed ID: 34512027
[TBL] [Abstract][Full Text] [Related]
5. circ_0002060 Enhances Doxorubicin Resistance in Osteosarcoma by Regulating the miR-198/ABCB1 Axis.
Ji Y; Liu J; Zhu W; Ji J
Cancer Biother Radiopharm; 2023 Nov; 38(9):585-595. PubMed ID: 33351694
[No Abstract] [Full Text] [Related]
6. LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; He P; Zeng M
Exp Mol Med; 2023 Apr; 55(4):831-843. PubMed ID: 37009803
[TBL] [Abstract][Full Text] [Related]
7. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
[TBL] [Abstract][Full Text] [Related]
8. Has_circ_0010220 regulates the miR-574-3p/IL-6 axis to increase doxorubicin resistance in osteosarcoma.
Gu Y; Wang G; Ran B
Hum Exp Toxicol; 2022; 41():9603271221131307. PubMed ID: 36250452
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
Liu Y; Liu X; Yang S
Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
[TBL] [Abstract][Full Text] [Related]
10. miR-652 Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HOXA9 and Regulating the PI3K/Akt Signaling Pathway.
Yang C; Chen Y; Xiong W; Xu K
J Oncol; 2022; 2022():4809312. PubMed ID: 35111226
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis.
Bai Y; Li Y; Bai J; Zhang Y
J Orthop Surg Res; 2021 Aug; 16(1):510. PubMed ID: 34407841
[TBL] [Abstract][Full Text] [Related]
12. [Hsa_circ_0006948 regulates the proliferation, migration and invasion in osteosarcoma by regulation of the expression of miR-490-3p target ATG7].
Dai W; Liu H; Zhang P
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):457-465. PubMed ID: 33902208
[No Abstract] [Full Text] [Related]
13. miRNA-331-3p Affects the Proliferation, Metastasis, and Invasion of Osteosarcoma through SOCS1/JAK2/STAT3.
Zu D; Dong Q; Chen S; Chen Y; Yao J; Zou Y; Lin J; Fang B; Wu B
J Oncol; 2022; 2022():6459029. PubMed ID: 36199788
[TBL] [Abstract][Full Text] [Related]
14. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.
Dong L; Qu F
J Mol Histol; 2020 Aug; 51(4):329-340. PubMed ID: 32472335
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
17. MicroR-542-3p can mediate
Cai W; Xu Y; Zuo W; Su Z
Aging (Albany NY); 2019 Jan; 11(1):18-32. PubMed ID: 30636169
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.
Cao M; Tian K; Sun W; Xu J; Tang Y; Wu S
Exp Ther Med; 2022 Jan; 23(1):97. PubMed ID: 34976139
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
Guo W; Li W; Yuan L; Mei X; Hu W
Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
[TBL] [Abstract][Full Text] [Related]
20. MiR-25-3p Serves as an Oncogenic MicroRNA by Downregulating the Expression of Merlin in Osteosarcoma.
Rao HC; Wu ZK; Wei SD; Jiang Y; Guo QX; Wang JW; Chen CX; Yang HY
Cancer Manag Res; 2020; 12():8989-9001. PubMed ID: 33061594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
